Eterna Therapeutics Inc (ERNA)

Finanzdaten der Eterna Therapeutics Inc-Aktie (ERNA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	176.47% 0.047	0.017	0.051	-	-
Cost Of Revenue	7.58% 0.061	0.066	0.12	-	-
Gross Profit	71.43% -0.014	-0.049	-0.069	-	-
Operating Expenses	1.00% 5.773	5.716	5.436	4.549	5.316
Benefits Costs and Expenses	8.36% 6.69	6.174	5.65	-	-
Costs And Expenses	8.36% 6.69	6.174	5.65	-	-
Operating Income/Loss	0.38% -5.787	-5.765	-5.505	-4.549	-5.316
Nonoperating Income/Loss	118.37% -0.856	-0.392	-0.094	0.045	-0.095
Income/Loss From Continuing Operations Before Tax	7.89% -6.643	-6.157	-5.599	-4.504	-5.411
Income Tax Expense/Benefit	200.00% 0.004	-0.004	-0.008	0.004	0.005
Income/Loss From Continuing Operations After Tax	8.03% -6.647	-6.153	-5.591	-4.508	-5.416
Net Income/Loss	8.03% -6.647	-6.153	-5.591	-4.508	-5.416
Preferred Stock Dividends And Other Adjustments	100.00% -	0.008	-	0.008	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	16,294% 5.41	0.033	5.41	5.303	5.127
Diluted Average Shares	16,294% 5.41	0.033	5.41	5.303	5.127
Basic Earnings Per Share	7.89% -1.23	-1.14	-1.03	-0.85	-1.06
Diluted Earnings Per Share	7.89% -1.23	-1.14	-1.03	-0.85	-1.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	100.00% -	0.008	-	0.008	-